CHANEL STARKE: Open Payments
NPI 1568023844 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 22 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $173 |
| Boston Scientific Corporation | 1 | $143 |
| SCPHARMACEUTICALS INC. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| PFIZER INC. | 3 | $57 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $35 |
| United Therapeutics Corporation | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: ONYX FRONTIER, General - Vascular Intervention, FUROSCIX, LEQVIO, EDARBI, VYNDAQEL, ENTRESTO, REPATHA.
Industry payments across FL — which companies pay providers there.
